NCT02780960View on ClinicalTrials.gov

Human Papillomavirus (HPV) Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial Neoplasia

NACompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

October 31, 2020

Conditions
Cervical Intra-epithelial Neoplasia Grade 1 or Worse
Interventions
DEVICE

HPV self-testing

Patients will perform HPV testing themselves at home.

Trial Locations (1)

1205

Geneva University Hospital, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT02780960 - Human Papillomavirus (HPV) Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial Neoplasia | Biotech Hunter | Biotech Hunter